NIH (@NIH) header
NIH (@NIH) profile picture

Official account of the National Institutes of Health. NIH...Turning Discovery Into Health®.   Privacy Policy: https://xitter-newx.xyz-mikolabs.workers.dev/t.co/JibTXKbFtc Engagement ≠ endorsement

Bethesda, Maryland, USA
Joined June 2008
Hearing is fundamental to how we communicate, connect with loved ones, and experience the world around us. Protecting it is an important part of preserving quality of life, especially for patients undergoing lifesaving treatment. Cisplatin is one of the most widely-used cancer treatments, but it comes with a significant challenge: it can cause permanent hearing loss in up to half of patients who receive it. At NIH’s National Institute on Deafness and Other Communication Disorders, Dr. Lisa Cunningham and her lab are working to address this challenge. Her team is studying statins, FDA-approved cholesterol-lowing medications that could be repurposed to protect the delicate structures of the inner ear from cisplatin-related damage while preserving the drug’s ability to fight cancer. This work reflects an important goal of NIH research: not only helping to develop treatments that save lives but finding ways to reduce their long-term side effects so patients can live healthier lives after receiving care.
10
24
137
11,604
As cancer rates rise among adults under the age of 55, researchers are looking for new methods of early cancer detection and prevention. An NIH-supported study found that faster biological aging of the whole body and specific organs can increase the risk of early-onset cancer. Read how this study may inform future cancer prevention and detection efforts: bit.ly/4kdTAxb
29
30
10
76
13,402
NIH-supported research spanning decades helped pave the way for new treatment options for people living with fibrodysplasia ossificans progressiva (FOP), an ulta-rare and devastating genetic disease. Read more:
2
7
1
32
9,620
Autoimmune diseases occur when the immune system mistakenly attacks the body's own tissues. NIH researchers at the Systemic Autoimmunity Branch in NIAMS are exploring how the immune system normally maintains balance and what goes wrong in autoimmune diseases. By studying both the underlying biology, including neutrophil extracellular traps (NETs), and the experiences of patients over time, researchers hope to uncover new pathways for treatment and improve quality of life for people living with conditions like lupus and rheumatoid arthritis. The branch is also dedicated to training the next generation of scientists and physician-scientists who will advance discoveries in autoimmune disease research and patient care.
140
157
20
1,036
59,486
Native communities bring generations of knowledge, strengths and healing traditions to addressing addiction and pain. In a new blog, Dr. Nora Volkow, Director of National Institute on Drug Abuse, explores how NIH’s N CREW Program is supporting research led by Tribes and Native-serving organizations. 🔗 bit.ly/3Vfq284
3
6
2
13
4,677
About 2 to 3 of every 1,000 children in the United States are born with detectable hearing loss. Research has shown that identifying hearing loss early, and beginning language and other interventions as soon as possible, can make a meaningful difference in a child’s development. That is why advances in hearing research are so important. At NIH’s National Institute on Deafness and Other Communication Disorders (NIDCD), decades of scientific discovery have helped deepen our understanding of hearing and helped advance solutions across the continuum of care. Beyond early detection, NIDCD research has also helped advance technologies such as cochlear implants, which can provide access to sound for people with severe or profound hearing loss. Continued investment in NIH hearing research can help drive the next generation of discoveries and technologies to improve the quality of life of babies born with hearing loss.
20
44
6
262
18,139
🔬GLP-1 medications have transformed the landscape of obesity and diabetes treatment. Now, mounting research suggests they may also be used to treat substance use disorders, by modulating the brain’s dopamine reward system as well as numerous other systems throughout the body. Read the full commentary from NIDA Director Nora Volkow and Eric Wargo in @ScienceMagazine ➡️ bit.ly/4emtunN
9
13
38
6,533
NEWS: Two ‘forever chemicals’ associated with higher risk of aggressive breast cancer in NIH analysis.
13
19
2
36
13,748
NIH researchers examined immune responses in 45 healthy adults and identified key immune markers associated with protection and increased risk during a second dengue infection. Learn more about this important advance in dengue research:
4
8
24
7,742
New resource from NIH's Replication Prize: a compilation of real-world strategies scientists have used to build replication into their research. Track 2 winners share exactly what they did — their methods, the barriers they hit, and how they sustained the practice. Practical, not theoretical. Useful read for anyone trying to make their own research more rigorous and reproducible: bit.ly/4syktOn
2
5
15
9,676
Clinical fellows are helping drive discovery at NIH while building skills that will shape the future of biomedical research. Hear from Dr. Jonathan Fischell about his experience as an NIH Clinical Fellow and the opportunities available through NIH training programs. Ready to take the next step in your research career? Explore training opportunities at NIH: bit.ly/4BI4hhv
4
2
8
6,003
NEWS: NIH-funded clinical trial shows mobile units may help overcome significant barriers to accessing HIV and addiction treatment, but replication is needed. Read the full story ➡️ bit.ly/4Ad4Dv7
8
6
3
18
5,511
The brain’s 86 billion neurons make it one of science’s hardest puzzles, so the tools we use matter. NINDS’s Dr. Amy Bany Adams and Dr. Amir Tamiz explore New Approach Methodologies (NAMs) and how new and established methods work better together: bit.ly/4eJLSHm
2
6
1
28
5,932
After an extraordinary career spanning more than three decades as the director of the National Institutes on Aging (NIA), Dr. Richard Hodes is retiring on December 7, 2026. Under Dr. Hodes’s leadership, we have seen great progress in the field of Alzheimer’s disease (AD) and AD-related dementias (AD/ADRD) research, including in the areas of genetics, prevention, diagnostics, and care, reshaping what is possible for people living with AD/ADRD. In addition, his instrumental work in pioneering the field of geroscience will have lasting impact on improving the health and well-being of older adults. Dr. Hodes leaves an incredible legacy of scientific leadership and public service. We are deeply grateful for his enduring contributions to NIH and the health of the American people. Read my full statement: bit.ly/4ij4pfW
12
17
1
105
9,248
National Institutes of Health (NIH) researchers demonstrated that tracking physical activity over a full year revealed almost twice as many disease risk factors as the one-week snapshots typically obtained by wearable studies. Read more:
9
12
4
37
12,981
The new NIH Division on Women’s Health Research will lead the way in translating gold-standard research into impactful treatments for conditions like infertility and certain cancers that impact countless women every day. The division will respond to President Trump's Executive Order “Advancing Women’s Health to Improve Outcomes in All Phases of Life,” which seeks to strengthen scientific research, accelerate medical breakthroughs, and improve health outcomes for American women and girls.
40
55
6
337
32,474
NIH retweeted
Under @POTUS and @FLOTUS' leadership, women's health is finally getting the attention it deserves. 🇺🇸 From menopause care and lower fertility drug costs to maternal health and research, HHS is advancing women's health at every stage of life. See the results: hhs.gov/press-room/wtas-hhs-…
24
90
3
368
80,541
🔬 What makes being a Lasker Clinical Research Scholar so unique? For Dr. Chris Grunseich, it’s “the ability to collaborate with experts here in the intramural program, both in the clinical and basic labs.” Through the Lasker Clinical Research Scholars Program, Dr. Grunseich has had the opportunity to collaborate with leading MRI scientists to develop MRI as a biomarker for patients with neuromuscular disease. 🔗 Learn more and apply by Friday, November 6, 2026: bit.ly/43ghMmb.
6
25
8,406
Five months after the 2023 East Palestine, Ohio train derailment, NIH-supported researchers collected urine samples from residents living within about one mile of the site to better understand their exposure to hazardous chemicals. Nearly 75% of participants had detectable levels of a vinyl chloride metabolite. These findings can help researchers better understand potential implications for affected communities. 🔬 Read the study: bit.ly/4f1Dy5N.
8
36
11
89
19,687